Ranitidine induced hepatitis

Journal of Gastrointestinal and Liver Diseases

Volumn 19, Issue 3, 2010, Pages 337-338

  Lee, Tae Hoon ^a   Vega, Kenneth J ^b   El Khoury, Joe Gerges ^a  

^a MARSHALL UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RANITIDINE;

ADULT; CASE REPORT; DRUG WITHDRAWAL; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; HEPATITIS; HISTOPATHOLOGY; HUMAN; LABORATORY TEST; LETTER; LIVER BIOPSY; MALE; PHYSICAL EXAMINATION; SEROLOGY;

ADULT; BIOPSY; DRUG-INDUCED LIVER INJURY; HISTAMINE H2 ANTAGONISTS; HUMANS; LIVER; MALE; RANITIDINE;

EID: 78650092883     PISSN: 18418724     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (8)

1. Dobbs JH, Muir JG, Smith RN. H2-antagonists and hepatitis. Ann Intern Med 1986; 105: 803.
2. Ramrakhiani S, Brunt EM, Bacon BR. Possible cholestatic injury from ranitidine with a review of the literature. Am J Gastroenterol 1998; 93: 822-826.
3. Yokoyama M, Yokoyama A, Mori S, et al. Inducible histamine protects mice from P. acnes-primed and LPS-induced hepatitis through H2-receptor stimulation. Gastroenterology 2004; 127: 892-902.
4. Halparin LS. Adverse effects of ranitidine therapy. Can Med Assoc J 1984; 130: 668, 672.
5. Hiesse C, Cantarovich M, Santelli C, et al. Ranitidine hepatotoxicity in renal transplant patient. Lancet 1985; 1: 1280.
6. Lauritsen K, Havelund T, Rask-Madsen J. Ranitidine and hepatotoxicity. Lancet 1984; 2: 1471.
7. Graham DY, Opekun AR, Smith JL, Schwartz JT. Ranitidine and hepatotoxicity. Ann Intern Med 1985; 102: 416.
8. Devuyst O, Lefebvre C, Geubel A, Coche E. Acute cholestatic hepatitis with rash and hypereosinophilia associated with ranitidine treatment. Acta Clin Belg 1993; 48: 109-114.